IOL CHEMICALS & PHARM. | RPG LIFE SCIENCES | IOL CHEMICALS & PHARM./ RPG LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 29.7 | 45.7% | View Chart |
P/BV | x | 1.5 | 8.2 | 18.9% | View Chart |
Dividend Yield | % | 1.0 | 0.8 | 128.0% |
IOL CHEMICALS & PHARM. RPG LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
RPG LIFE SCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ RPG LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,012 | 53.0% | |
Low | Rs | 272 | 452 | 60.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 310.0 | 121.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 40.9 | 58.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 50.3 | 62.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 12.00 | 33.3% | |
Avg Dividend yield | % | 1.0 | 1.6 | 60.3% | |
Book value per share (Unadj.) | Rs | 256.8 | 186.0 | 138.1% | |
Shares outstanding (eoy) | m | 58.71 | 16.54 | 355.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.4 | 45.4% | |
Avg P/E ratio | x | 17.1 | 17.9 | 95.3% | |
P/CF ratio (eoy) | x | 12.8 | 14.6 | 88.0% | |
Price / Book Value ratio | x | 1.6 | 3.9 | 40.0% | |
Dividend payout | % | 16.9 | 29.3 | 57.5% | |
Avg Mkt Cap | Rs m | 23,743 | 12,109 | 196.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,171 | 143.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,128 | 432.3% | |
Other income | Rs m | 256 | 48 | 533.5% | |
Total revenues | Rs m | 22,427 | 5,176 | 433.3% | |
Gross profit | Rs m | 2,257 | 1,035 | 218.0% | |
Depreciation | Rs m | 462 | 155 | 298.0% | |
Interest | Rs m | 165 | 12 | 1,432.2% | |
Profit before tax | Rs m | 1,887 | 917 | 205.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 240 | 205.9% | |
Profit after tax | Rs m | 1,391 | 676 | 205.7% | |
Gross profit margin | % | 10.2 | 20.2 | 50.4% | |
Effective tax rate | % | 26.2 | 26.2 | 100.1% | |
Net profit margin | % | 6.3 | 13.2 | 47.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,641 | 366.1% | |
Current liabilities | Rs m | 5,025 | 1,028 | 488.9% | |
Net working cap to sales | % | 20.9 | 31.4 | 66.6% | |
Current ratio | x | 1.9 | 2.6 | 74.9% | |
Inventory Days | Days | 43 | 46 | 94.9% | |
Debtors Days | Days | 8 | 266 | 3.1% | |
Net fixed assets | Rs m | 11,017 | 1,553 | 709.4% | |
Share capital | Rs m | 587 | 132 | 443.8% | |
"Free" reserves | Rs m | 14,490 | 2,944 | 492.2% | |
Net worth | Rs m | 15,077 | 3,076 | 490.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 4,194 | 493.2% | |
Interest coverage | x | 12.5 | 80.7 | 15.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.2 | 87.7% | |
Return on assets | % | 7.5 | 16.4 | 45.9% | |
Return on equity | % | 9.2 | 22.0 | 42.0% | |
Return on capital | % | 13.6 | 30.2 | 45.1% | |
Exports to sales | % | 26.7 | 31.7 | 84.4% | |
Imports to sales | % | 0 | 3.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 1,624 | 365.1% | |
Imports (cif) | Rs m | NA | 201 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,624 | 365.1% | |
Fx outflow | Rs m | 6,052 | 201 | 3,018.4% | |
Net fx | Rs m | -122 | 1,424 | -8.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 908 | 134.6% | |
From Investments | Rs m | -1,200 | -1,058 | 113.4% | |
From Financial Activity | Rs m | -41 | -171 | 24.0% | |
Net Cashflow | Rs m | -18 | -321 | 5.7% |
Indian Promoters | % | 48.2 | 72.8 | 66.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 2.3 | 72.6% | |
FIIs | % | 1.4 | 0.6 | 250.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 27.2 | 190.5% | |
Shareholders | 130,003 | 21,866 | 594.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | RPG LIFE SCIENCES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.15% | -0.05% | 0.14% |
1-Month | 9.49% | -0.50% | 2.47% |
1-Year | -0.06% | 90.90% | 52.95% |
3-Year CAGR | -11.16% | 56.14% | 14.91% |
5-Year CAGR | 15.75% | 44.36% | 19.34% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the RPG LIFE SCIENCES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of RPG LIFE SCIENCES the stake stands at 72.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of RPG LIFE SCIENCES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
RPG LIFE SCIENCES paid Rs 12.0, and its dividend payout ratio stood at 29.3%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of RPG LIFE SCIENCES.
For a sector overview, read our pharmaceuticals sector report.
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.